MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clinical correlates of apathy in Parkinson´s disease

J. Arena, L. Fiorentini, C. Obarrio, M. Merello (Buenos Aires, Argentina)

Meeting: 2024 International Congress

Abstract Number: 341

Keywords: Apathy, Parkinson’s

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: To investigate the demographic and clinical correlates of apathy in a group of patients from a Movement Disorders clinic in Latin America.

Background: Apathy is a common non-motor symptom affecting almost 40% of patients with Parkinson’s disease and has been associated with a higher burden of the disease and poorer quality of life. It has even been proposed as a risk factor for motor complications and cognitive impairment. No specific or effective treatments are currently available and its pathophysiology has not been completely elucidated. Data on patients from South America, and their possible particular traits, is lacking.

Method: We examined a series of 28 patients that volunteered for participation on a longitudinal study for the study of cognitive and psychiatric impairment in PD. Neurological examination and cognitive evaluation were performed trough Starkstein’s apathy scale, Parkinson´s anxiety scale, MOCA, MDS-UPDRS. We performed two-tailed Mann Whitney U test to compare an apathetic and a non-apathetic group (as per Starkstein’s scale).

Results: Half of the recruited patients resulted to be apathetic. Although it did not reach statistical significance, the apathetic group seemed to have a longer disease duration (with median values of 46 vs 80 months, p 0.07). Our apathetic group resulted to be older than the non-apathetic (68.5 non-apathetic vs 75.5 years apathetic group, p 0.011). We did not find differences in their motor scores (MDS-UPDRS III of 31 vs 34.5, p 0.289) or LED (561 vs 692.5, p 0.423). We did not find statistically significant differences in Beck depression scores in these patients (8.5 vs 9.5, p 0.535), and the apathetic group resulted to score higher on anxiety scales (7.5 vs 14, p 0.01). Cognitive evaluation showed no statistically significant differences between the non-apathetic and apathetic groups (median MOCA values of 26 vs 22, p 0.07).

Conclusion: Apathy seems to be a very frequent complication in our population, and seemed to be unrelated to the co-occurrence of depression or cognitive impairment. Apathetic parkinsonian patients in our cohort seemed to be older and more anxious. There was not a statistically significant relationship with motor scores. Apathy seems to not be just a trait of disease progression, but an independent neuropsychiatric syndrome.

To cite this abstract in AMA style:

J. Arena, L. Fiorentini, C. Obarrio, M. Merello. Clinical correlates of apathy in Parkinson´s disease [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/clinical-correlates-of-apathy-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clinical-correlates-of-apathy-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley